Clinical Trial Update: A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 study of tasquinimod in men with metastatic castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Tasquinimod (tasquinimod)

Snippet

Sponsor: Active Biotech AB | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED